MCL · Oncology · 4 drugs · 2 indications
| Drug | Company | Mechanism | Modality | Route | Stage |
|---|---|---|---|---|---|
| Calquence | AZN | BTK inhibitor | Small molecule | ORAL | APPROVED |
| Jaypirca | LLY | BTK inhibitor (non-covalent) | Small molecule | ORAL | APPROVED |
| Tecartus | GILD | CD19 CAR-T | Cell therapy | IV | APPROVED |
| Imbruvica | ABBV | BTK inhibitor | Small molecule | PO | APPROVED |